MedPath

BETH ISRAEL DEACONESS MEDICAL CENTER

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
1896-01-01
Employees
-
Market Cap
-
Website
https://www.bidmc.org/

Effect of Standardized Consent for Urogynecological Procedures on Patient Satisfaction

Not Applicable
Completed
Conditions
Pelvic Organ Prolapse
Urinary Incontinence
Interventions
Other: Standardized visual presentation
First Posted Date
2014-12-10
Last Posted Date
2018-12-06
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
64
Registration Number
NCT02313701
Locations
πŸ‡ΊπŸ‡Έ

BIDMC, Boston, Massachusetts, United States

Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators

Not Applicable
Completed
Conditions
Parkinson's Disease
Interventions
Other: Deep brain stimulator
First Posted Date
2014-10-30
Last Posted Date
2017-05-08
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
8
Registration Number
NCT02278406
Locations
πŸ‡ΊπŸ‡Έ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer

Not Applicable
Terminated
Conditions
Breast Cancer
Interventions
Other: MRI
Other: CESM
First Posted Date
2014-10-27
Last Posted Date
2020-03-16
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
44
Registration Number
NCT02275871
Locations
πŸ‡ΊπŸ‡Έ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique

Not Applicable
Active, not recruiting
Conditions
Labor Pain
Interventions
Device: ultrasound guidance
Device: palpation guidance
First Posted Date
2014-10-22
Last Posted Date
2024-05-07
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
110
Registration Number
NCT02271100
Locations
πŸ‡ΊπŸ‡Έ

Beth Isreal Deaconess Medical Center, Boston, Massachusetts, United States

Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms

Early Phase 1
Completed
Conditions
Insomnia
Interventions
Drug: Placebo
First Posted Date
2014-10-20
Last Posted Date
2017-03-15
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
8
Registration Number
NCT02268565
Locations
πŸ‡ΊπŸ‡Έ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Challenging the Inflammatory Response System in Insomnia Disorder

Completed
Conditions
Insomnia
Interventions
Behavioral: Cold Pressor Test
First Posted Date
2014-10-10
Last Posted Date
2019-07-22
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
44
Registration Number
NCT02261597
Locations
πŸ‡ΊπŸ‡Έ

BIDMC, Boston, Massachusetts, United States

Stepping Up for Safety: Improving Teamwork at the Planned Parenthood Affiliates Through the TeamSTEPPS Model

Not Applicable
Completed
Conditions
Improving Team Work at the Planned Parenthood Affiliates
Interventions
Behavioral: Team training using the TeamSTEPPS model
First Posted Date
2014-10-09
Last Posted Date
2020-11-24
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
40
Registration Number
NCT02260245

Neuromuscular Blockade for Post-Cardiac Arrest Care

Phase 2
Completed
Conditions
Cardiac Arrest
Interventions
Drug: Normal Saline
First Posted Date
2014-10-09
Last Posted Date
2021-01-29
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
83
Registration Number
NCT02260258
Locations
πŸ‡ΊπŸ‡Έ

Brigham and Women's Hospital, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Robert Swor, Royal Oak, Michigan, United States

and more 2 locations

Evaluation of the PelvicSim Simulator for Training in Intrauterine Device Insertions

Not Applicable
Completed
Conditions
Contraceptive Devices, Intrauterine
Education, Medical
Interventions
Device: Manufacturer model
Other: PelvicSim
First Posted Date
2014-08-19
Last Posted Date
2017-05-24
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
60
Registration Number
NCT02220205
Locations
πŸ‡ΊπŸ‡Έ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1
Active, not recruiting
Conditions
Acute Myeloid Leukemia, in Relapse
Recurrent Adult Acute Myeloid Leukemia
Interventions
First Posted Date
2014-07-30
Last Posted Date
2025-01-24
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
33
Registration Number
NCT02204085
Locations
πŸ‡ΊπŸ‡Έ

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Β© Copyright 2025. All Rights Reserved by MedPath